{"name":"Stephen J. Kim, MD","slug":"stephen-j-kim-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNbDBtbUVSTmVKNW1XaVFLZXNmSGJwZkVJNklRUkl5UE52U0tXdlYtUlJNSmNZeHc5X29JaE4wcmZRTUJBVzExaXZOY3JPMHlZS3FuMllsbXZMaGZoNHpXYXhVaE90bV9PUUVwX0o2S3oyUWxGU1dHaXYzVnQ5WE5DWVBHX0RqQWNpMXB6dC1EOWxrMlhpRkZnR3F3cjBlVDc2RklpeQ?oc=5","date":"2025-10-20","type":"pipeline","source":"Cedars-Sinai","summary":"Drug Combo Cuts Risk of Death in Advanced Prostate Cancer by 40% - Cedars-Sinai","headline":"Drug Combo Cuts Risk of Death in Advanced Prostate Cancer by 40% - Cedars","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBtTDBWeGQyU3EzV2RPR2NTWkJLdDhyQkx2ZnI0WjNtekxJWEd4b0ozOENqRE52RGJFTlFOVlZ1Yk92VDlLRWhUbUFJUml2YllvZzNxYjcwUERnNGJMQlJXQg?oc=5","date":"2025-10-19","type":"pipeline","source":"NEJM","summary":"Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer - NEJM","headline":"Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9VUVUwODNMdFdaZ1BRbENyUVVwNW9qdXhwdWFVUUV4bU13N3ZvNVpXLUFNcmZjejZuZ0hJOTk4VGQ4enVld0lUQkZ0R1pmTnFQSHpENkl2eHEtNHRlODdSaA?oc=5","date":"2023-10-18","type":"pipeline","source":"NEJM","summary":"Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer - NEJM","headline":"Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNYUFNN2dvc0F4WUZxQ1g1WjZvakhzOGdybEtncXRacW1Sa1c3V1RPd2czSk51TU44NGhjbXZNaDdrejFpNkRFTFhvQ01iOEE0c0l5WUgxNDdlMG0wTnp6aVU0aHJVYVJKV2JjLTJkeXJ5dWdVbnNxUjRPaXRnVVZZbURxNUJVem1jTkM2Qks2ZjNPaXAtdkFEZGc0eU5MQUx6eHFiNlhHSzA1d25LSEhrNXQ1emNFRjlKOFRmaVZXbG4wbVh5VS11RTUwcVBnZWNhME9XcVQ3dzdHbnJQT1E?oc=5","date":"2019-07-27","type":"pipeline","source":"Sun Sentinel","summary":"5.6 billion opioid pills flooded the state, and rogue South Florida doctors helped get them on the streets - Sun Sentinel","headline":"5.6 billion opioid pills flooded the state, and rogue South Florida doctors helped get them on the streets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1NZW5mbUtNODBXYXV0dXFIb2lrSlhNbkx1SFZONUZWY21WU1hndk1yVm9lYmpiOVU0cmI5dUc3T0pHMmdxMmliSnFNYUR2THhXbm10SjJfenh2dDdna0tOcWxoV0VsZ1I2TWJvbUZpWHFGYXE3OE0tVVB3?oc=5","date":"2019-03-01","type":"pipeline","source":"American Academy of Ophthalmology","summary":"Fighting ROP With Anti-VEGF Therapy - American Academy of Ophthalmology","headline":"Fighting ROP With Anti-VEGF Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5vUl9TZDNWRW9RY2tDU1NGRHlteGJZS2Y2N1EtV1BTMDE3NnpleXNGN2JRNUtzb2pKU3piajVMQXZGSTJaQlU4QVBNQWVjcW9xSGtQcklkQldib0RzMzZR?oc=5","date":"2018-01-26","type":"pipeline","source":"NEJM","summary":"Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma - NEJM","headline":"Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}